Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorthalidone for Resistant Hypertension in Kidney Transplant Patients
NCT02030314Phase 4Withdrawn
- Sponsor
- Virginia Commonwealth University
- Start
- Jul 2013
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of chlorthalidone in resistant hypertension (RH), sponsored by Virginia Commonwealth University. Planned start Jul 2013; status: withdrawn.
02
Drugs
chlorthalidone
03
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on NCT02030314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02030314.